methionine has been researched along with Achondroplasia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boot-Handford, RP; Briggs, MD; Heinegård, D; Kadler, KE; Knowles, L; Meadows, RS; Piróg-Garcia, KA; Thornton, DJ | 1 |
Buckley, MF; Elakis, G; Gardener, G; Inglis, G; Roscioli, T; Susman, RD; Zankl, A | 1 |
2 other study(ies) available for methionine and Achondroplasia
Article | Year |
---|---|
Reduced cell proliferation and increased apoptosis are significant pathological mechanisms in a murine model of mild pseudoachondroplasia resulting from a mutation in the C-terminal domain of COMP.
Topics: Achondroplasia; Animals; Apoptosis; Cell Proliferation; Chondrocytes; Disease Models, Animal; Dwarfism; Endoplasmic Reticulum; Extracellular Matrix Proteins; Female; Glycoproteins; Male; Matrilin Proteins; Methionine; Mice; Mice, Knockout; Mutation; Osteochondrodysplasias; Phenotype; Protein Structure, Tertiary; Threonine | 2007 |
Prenatal and postnatal presentation of severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN) due to the FGFR3 Lys650Met mutation.
Topics: Acanthosis Nigricans; Achondroplasia; Amino Acid Substitution; Developmental Disabilities; Female; Fetus; Humans; Infant, Newborn; Lysine; Male; Methionine; Mutation, Missense; Pregnancy; Receptor, Fibroblast Growth Factor, Type 3; Ultrasonography, Prenatal | 2008 |